Inventor · disambiguated record
Xavier Preville
Also filed as: PREVILLE XAVIER · PREVILLE XAVIER-EDMOND-EDOUARD · PRÉVILLE XAVIER
7 granted patents·4 pending applications·27 citations·filing 2006–2024
80Inventor score
Files withEMERGENCE THERAPEUTICS GMBH2PREVILLE XAVIER-EDMOND-EDOUARD2ROUSSY INST GUSTAVE2BLINK BIOMEDICAL SAS1LILLY CO ELI1
Top patents by PatentIndex Score
11 records- 0189US10765710B2Combination of oncolytic virus with immune checkpoint modulatorsROUSSY INST GUSTAVE·Filed 2015·Granted Sep 8, 2020·13 cites·14 claims
- 0283US8628779B2Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof. therapeutic uses thereofPREVILLE XAVIER-EDMOND-EDOUARD·Filed 2006·Granted Jan 14, 2014·8 cites·43 claims
- 0379US8637039B2Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereofPREVILLE XAVIER-EDMOND-EDOUARD·Filed 2010·Granted Jan 28, 2014·5 cites·45 claims
- 0478US12049500B2Anti-nectin-4-antibodies and uses thereofEMERGENCE THERAPEUTICS GMBH·Filed 2022·Granted Jul 30, 2024·1 cites·20 claims
- 0570US12419964B2Antibody drug conjugate (ADC) targeting Nectin 4 and comprising an exatecan payloadLILLY CO ELI·Filed 2024·Granted Sep 23, 2025·0 cites·11 claims
- 0664US2025018053A1Anti-nectin-4-antibodies and uses thereofEMERGENCE THERAPEUTICS GMBH·Filed 2024·Application pending·0 cites
- 0759US9387243B2Recombinant protein carrying human papillomavirus epitopes inserted in an adenylate cyclase protein or fragment thereof therapeutic uses thereofPASTEUR INSTITUT·Filed 2013·Granted Jul 12, 2016·0 cites·33 claims
- 0853US2020376052A1Combination of oncolytic virus with immune checkpoint modulatorsROUSSY INST GUSTAVE·Filed 2020·Application pending·0 cites
- 0940US2018028626A1Immunotherapeutic vaccine and antibody combination therapyTRANSGENE SA·Filed 2016·Application pending·0 cites
- 1037US2023192845A1Cd96-binding agents as immunomodulatorsBLINK BIOMEDICAL SAS·Filed 2018·Application pending·0 cites
- 1136US9486524B2Composition for eliciting a specific CTL response, comprising a lympho-ablative compound and a molecule that contains antigenic sequences and targets professional antigen presenting cellsPREVILLE XAVIER·Filed 2007·Granted Nov 8, 2016·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Xavier Preville files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →